Mercedes Paine
Child & Adolescent Psychiatry · Hackensack, NJNPI 1831319508
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 302 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 11.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,013 and has fallen 70.6% since, to $298 in 2025. Among child & adolescent psychiatry clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 302 payments — averaging $15.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neos Therapeutics, LP$538
- AbbVie$486
- Teva Pharmaceuticals USA, Inc.$408
- Validus Pharmaceuticals LLC$360
- Otsuka America Pharmaceutical, Inc.$352
- Takeda Pharmaceuticals U.S.A., Inc.$264
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,44598%
- Education$1092%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neos Therapeutics, LP | 40 | $538 |
| AbbVie(2 entities) | 32 | $486 |
| Teva Pharmaceuticals USA, Inc. | 33 | $408 |
| Validus Pharmaceuticals LLC | 1 | $360 |
| Otsuka America Pharmaceutical, Inc. | 17 | $352 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $264 |
| Lundbeck LLC | 17 | $254 |
| Vanda Pharmaceuticals Inc. | 16 | $219 |
| Supernus Pharmaceuticals, Inc. | 21 | $215 |
| Sunovion Pharmaceuticals Inc. | 15 | $201 |
| Neurocrine Biosciences, Inc. | 13 | $178 |
| Bausch Health US, LLC | 11 | $161 |
| Tris Pharma Inc | 8 | $125 |
| Corium, LLC | 11 | $114 |
| Ironshore Pharmaceuticals Inc. | 7 | $98 |
| Arbor Pharmaceuticals, Inc. | 6 | $90 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $80 |
| Almatica Pharma LLC | 5 | $69 |
| Johnson & Johnson | 5 | $64 |
| Axsome Therapeutics, Inc. | 3 | $45 |
| Harmony Biosciences LLC | 3 | $43 |
| Adlon Therapeutics L.p. | 3 | $36 |
| Shire North American Group Inc | 2 | $29 |
| Jazz Pharmaceuticals Inc. | 2 | $29 |
| Vertical Pharmaceuticals, LLC | 2 | $28 |
| Rhodes Pharmaceuticals L.p. | 2 | $26 |
| Novo Nordisk | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,555 in reported general payments places this provider in the 90th percentile of 137 child & adolescent psychiatry providers in New Jersey.
See all child & adolescent psychiatry providers in New Jersey →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Effexor XrVenlafaxine Hcl | 22 | $15,652 |
| TrintellixVortioxetine Hydrobromide | 16 | $8,460 |
| Methylphenidate ErMethylphenidate Hcl | 13 | $1,543 |
| Bupropion XlBupropion Hcl | 26 | $1,103 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 47 | $1,038 |
| Clonazepam | 70 | $699 |
| Aripiprazole | 15 | $640 |
| Sertraline Hcl | 41 | $496 |
| Olanzapine | 13 | $388 |
| Duloxetine Hcl | 16 | $350 |
| Trazodone Hcl | 37 | $337 |
| Escitalopram Oxalate | 29 | $307 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 11 | $288 |
| Bupropion Hcl SrBupropion Hcl | 18 | $288 |
| Fluoxetine Hcl | 32 | $214 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $264 | $8,46016 claims |
| Almatica Pharma LLCSertraline Hcl | $69 | $49641 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 137 child & adolescent psychiatry providers in New Jersey.
Other child & adolescent psychiatry in Hackensack
- Valeria KorshunovaHackensack$12K
- Sonia OquendoHackensack$381
- Ravinder BhallaRidgewood$125K
- Steven DyckmanEast Brunswick$53K
- Eric BartkyLivingston$51K
- Bohdan CzartoryskyParsippany$21K
- Akhtar HossainSomerville$19K
- Suzanne LindNew Brunswick$18K
- Aykut OzdenEdgewater$17K
- Carol DobrzynskiBrick$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.